Clinical Trials Planned for Iris-Recognition-Based Patient Identification Software

Patientory, Inc. and IrisGuard collaborate to address patient identity challenges across the healthcare system to deliver greater clinical, financial, and administrative efficiencies.

SAN FRANCISCO /PRNewswire/ -- Today, Patientory Inc. and UK-based IrisGuard announced a collaboration to combine leading iris biometric technology and healthcare focused PTOYNet blockchain network for enhanced security measures. The HIPAA-compliant Patientory App, which already adheres to strict security requirements, will utilize the benefits of iris-recognition software to add another layer of authorization on the blockchain to help eliminate healthcare inefficiencies.

IrisGuard's proprietary EyePay™ mobile technology has been used by the United Nations Agencies, for preventing human trafficking by registering refugees and orphans through the High Commissioner for Refugees (UNHCR), and for the World Food Programme (WFP) providing iris-based registration and e-payment solutions to increase financial inclusion to millions of forcibly displaced refugees in the Middle-East.

Because EyePay™ Phone is blockchain-ready to authenticate and authorize patient identification and information in under three (3) seconds, there's great potential to expand the technology into healthcare on the Patientory, Inc software, which is powered by the PTOYNet blockchain.

"Patient identification is a growing problem in today's healthcare system," said Chrissa McFarlane, CEO and founder of Patientory, Inc. "This technology can help providers identify an individual with unparalleled accuracy, through iris-recognition and data matching. And because it's verified on the blockchain, it's scalable without sacrificing data security - which is one of the main problems with our current healthcare-data infrastructure."

According to statistics cited by Pew Research Center, up to 20% of patient records are not matched accurately within the same healthcare system, driving up costs, creating inefficiency, and risking patient safety.

Iris recognition can reduce the amount of fraud and abuse occurring within the pharmaceutical and insurance industries by ensuring patients are who they say they are. Coupled with a blockchain network, data management such as keeping a detailed log of information, patient histories, prescriptions and transactions will be more efficient and streamlined. Patientory, Inc. plans to roll out the technology first in pharmaceutical clinical trials this year.

"The innovative iris enabled EyePay Phone significantly improves patient privacy and confidence when sharing their online Electronic Medical Records (EMR) with healthcare stakeholders i.e. (physicians, hospitals, insurance companies, pharmacies and government etc.). The EyePay Phone and PTOYNet proactively enhances patient's peace of mind knowing that healthcare providers are deploying the most accurate biometric/blockchain identification technology available today in an effort to ensure efficiencies of scale, privacy and trust in the healthcare authentication and authorization processes. This is particularly important given that one out of three Americans had their health care data stolen or hacked recently." Commented Mr. Imad Malhas, CEO IrisGuard U.K.


About IrisGuard
IrisGuard was founded in 2001 and is a UK-based iris-recognition solutions company and the leading supplier of iris biometric technology platforms for large-scale humanitarian deployments, focused on managing trusted human authentication requirements for large populations. Since inception, IrisGuard has successfully registered and processed hundreds of millions individual irises, processed trillions of iris cross-comparisons and deployed thousands of units in 12 countries around the world. The IrisGuard suite of financial authentication and authorisation platforms is implemented across ATMs, supermarket POS transactions, microfinance, salary assurance, medical aid and remittances.

MEDIA CONTACT
Candice Stokes

208671@email4pr.com
www.venturepr.co
424-230-3770

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Patientory

Patientory, Inc. is a fully HIPAA-compliant, cybersecurity healthcare data solution that allows users to securely store, transfer and receive actionable insights into their health information. Its enterprise healthcare software aggregates data and provides population health management solutions for the health industry. Patientory, Inc. incorporates a dApp stack and integrates with PTOYNet blockchain network and PTOY token administered by the Patientory Association as well as other blockchains/distributed ledger technology to secure online medical information across platforms. It was incorporated in 2015 by Chrissa McFarlane, and is available on iOS, Android, and on desktop browsers. Patientory, Inc. is a member of the Patientory Association, a 501c(6) trade organization that connects the healthcare industry to emerging technology applications.